首页 正文

Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia

{{output}}
Acute myeloid leukemia (AML) is an aggressive, clonally heterogeneous, myeloid malignancy, with a 5-year overall survival of approximately 27%. It constitutes the most common acute leukemia in adults, with an incidence of 3-5 cases per 100,000 in the United St... ...